Chief executive officers (CEOs) in Indonesia have become slightly less optimistic about the Indonesian economy and politics. This makes sense considering the presence of simmering global trade tensions, sharp rupiah depreciation against the US dollar, and Bank Indonesia's recent series of interest rate hikes.
The Business Columns section of Indonesia Investments provides in-depth columns that exhibit an analysis regarding subjects that are both important for understanding the Indonesian business climate and have high news value in the current state of Indonesia's economy. As a whole these columns should provide the reader a thorough and detailed picture of multiple Indonesian business sectors and be a source of ideas or inspiration to invest - or not to invest - in specific sectors of the Indonesian economy.
One of the national industries that is heavily affected by the weak rupiah exchange rate is Indonesia's pharmaceutical industry. Considering around 90 percent of raw materials in the pharmaceutical industry need to be imported from abroad (in US dollars), production costs rise sharply in times of significant rupiah depreciation. It is estimated that materials imported from abroad account for about 75 percent of pharmaceutical companies' total production costs.
One of the companies, listed on the Indonesia Stock Exchange, that is experiencing a very good performance so far in 2018 is vertically integrated and diversified mining and metals company Aneka Tambang, a state-controlled entity. Not only did the company's corporate earnings and production figures surged in the first quarter of 2018 on the back of stronger commodity prices (and rising demand), but shares of Aneka Tambang also soared - by a whopping 45.60 percent - up to Friday (22/06).
In an extraordinary general meeting on Thursday (21/06), shareholders of Unilever Indonesia - which is among the biggest companies listed on the Indonesia Stock Exchange in terms of market capitalization - approved to sell the company's food spreads business to a subsidiary of KKR & Co, the New York-based global investment company that is engaged in a wide variety of sectors including private equity, energy, infrastructure, real estate, credit, and hedge funds.
The views expressed in these business columns are the views of the authors or the interviewed persons only and therefore do not necessarily reflect the views of Indonesia Investments. The authors are free to ventilate their opinions about the Indonesian business climate. Facts presented in these columns are the result of the author's own research or indicated sources, read disclaimer.